Get a glimpse into our company and investor data—powered by the PitchBook Platform
RD&C Research, Development & Consulting
Accelerator/IncLATEST DEAL TYPE
$37.4KLATEST DEAL AMOUNT
Owner and operator of a pharmaceutical company. The company provides a systemic analysis concept for impurity profiling drug process development and impurity related deviation management required in routine drug manufacturing.